Fig. 4
From: Therapeutic novelties in migraine: new drugs, new hope?
Overview of patients (%) achieving 2-h pain freedom in rimegepant phase III clinical trials. *Study 301; vs. placebo, p < 0.003. Study 302; vs. placebo, p < 0.001
Fig. 4 | The Journal of Headache and Pain
